BeStock  

Teva Pharmaceutical Industries TEVA

US equityMarket cap rank #452Infectious DiseaseCannabis & Hemp
$39.23 +$0.69 (+1.79%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $39.23 0.00%
Open$38.46
Prev close$38.54
Day range$38.30 – $39.91
Volume6.81M
Market cap$45.77B
P/E (TTM)91.2
Dividend yield–

Analyst view

ConsensusBuy
Analysts13
Average target$51.54+31.4% vs. price
  • Buy 100%
Low $45.94Now $39.23Avg $51.54High $57.00

Recent rating changes

The last 20 actions on file set price targets from $44.00 to $57.00, averaging $50.72.

DateFirmRatingTarget
19 Nov 2026 Leerink Partners BUY –
18 Nov 2026 Barclays BUY $50.00
17 Nov 2026 H.C. Wainwright BUY $54.00
16 Nov 2026 Argus Research BUY $50.00
12 Nov 2026 TD Cowen BUY $57.00
12 Nov 2026 Piper Sandler BUY $56.00
12 Nov 2026 Evercore BUY –
12 Nov 2026 H.C. Wainwright BUY $54.00
12 Nov 2026 Oppenheimer BUY $54.00
11 Nov 2026 BofA Securities BUY $48.00
4 Nov 2026 Scotiabank BUY $47.00
4 Nov 2026 Goldman Sachs BUY $55.00
4 Nov 2026 H.C. Wainwright BUY $54.00
4 Nov 2026 J.P. Morgan BUY $50.00
3 Nov 2026 BofA Securities BUY $48.00
3 Nov 2026 Scotiabank BUY $47.00
2 Nov 2026 H.C. Wainwright BUY $52.00
23 Oct 2026 Piper Sandler BUY $44.00
15 Oct 2026 Barclays BUY $47.00
12 Oct 2026 Leader Capital Markets BUY $45.94

Discussion

No comments yet — be the first to weigh in on TEVA.

Sign in to join the discussion.

Scroll to Top